Erten Yasemin, Tulmac Murat, Derici Ulver, Pasaoglu Hatice, Altok Reis Kadriye, Bali Musa, Arinsoy Turgay, Cengel Atiye, Sindel Sukru
Department of Internal Medicine, Section of Nephrology, Gazi Medical School, 32 Sokak 3/8 Bahcelievler, Ankara, Turkey.
Ren Fail. 2005;27(5):581-9. doi: 10.1080/08860220500200072.
This study was performed to investigate the potential relationship between left ventricular hypertrophy (LVH) and proinflammatory cytokines in hemodialysis (HD) patients and the effect of HD on cytokine production. Serum interleukin 1 beta (IL-1 beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) measurements and echocardiographic studies were performed in 35 stable HD patients. A variety of probable risk factors for LVH including age, HD duration, blood pressure (BP), body mass index, lipid profile, hemoglobin, albumin, parathormone and homocysteine levels were also investigated. Additionally, the effect of HD procedure on cytokine levels was evaluated. Predialysis serum levels of IL-1beta, IL-6, TNF-alpha, and homocysteine in HD patients were compared with 12 healthy subjects. Left ventricular hypertrophy was demonstrated in 20 (57%) of HD patients by echocardiography. Left ventricular mass index (LVMI) was correlated positively with systolic BP (r=0.556, p=0.001), diastolic BP (r=0.474, p=0.004), and serum levels of TNF-alpha (r=0.446, p=0.009). Multiple regression analysis showed that systolic BP and TNF-alpha levels were significant independent predictors of LVH. No relationship was observed between LVH and other parameters. The mean predialysis serum level of IL-6 was significantly higher in HD patients compared to healthy controls (15.7 +/- 8.7 vs. 7.3 +/- 0.7 pg/ mL, p=0.001). Predialysis serum levels of TNF-alpha in HD patients were higher when compared to healthy subjects, but the difference was not statistically significant (8.3 +/- 3 vs. 7 +/- 1.45 pg/mL, respectively, p>0.05). However, serum levels of IL-6 and TNF-alpha significantly elevated after HD, when compared to predialysis levels (from 15.7 +/- 8.7 to 17.8 +/- 9.5 pg/mL, p=0.001 and from 8.3 +/- 3.0 to 9.9 +/- 3.5 pg/mL p=0.004, respectively). As a conclusion, in addition to BP, proinflammatory cytokines, TNF-alpha in particular, seem to be associated with LVH in ESRD patients.
本研究旨在调查血液透析(HD)患者左心室肥厚(LVH)与促炎细胞因子之间的潜在关系,以及HD对细胞因子产生的影响。对35例稳定的HD患者进行了血清白细胞介素1β(IL-1β)、白细胞介素6(IL-6)和肿瘤坏死因子α(TNF-α)检测及超声心动图研究。还调查了多种LVH的可能危险因素,包括年龄、HD病程、血压(BP)、体重指数、血脂谱、血红蛋白、白蛋白、甲状旁腺激素和同型半胱氨酸水平。此外,评估了HD程序对细胞因子水平的影响。将HD患者透析前血清IL-1β、IL-6、TNF-α和同型半胱氨酸水平与12名健康受试者进行比较。通过超声心动图证实20例(57%)HD患者存在左心室肥厚。左心室质量指数(LVMI)与收缩压(r=0.556,p=0.001)、舒张压(r=0.474,p=0.004)和血清TNF-α水平(r=0.446,p=0.009)呈正相关。多元回归分析显示收缩压和TNF-α水平是LVH的重要独立预测因素。未观察到LVH与其他参数之间的关系。HD患者透析前血清IL-6的平均水平显著高于健康对照组(15.7±8.7对7.3±0.7 pg/mL,p=0.001)。HD患者透析前血清TNF-α水平高于健康受试者,但差异无统计学意义(分别为8.3±3对7±1.45 pg/mL,p>0.05)。然而,与透析前水平相比,HD后血清IL-6和TNF-α水平显著升高(分别从15.7±8.7升至17.8±9.5 pg/mL,p=0.001;从8.3±3.0升至9.9±3.5 pg/mL,p=0.004)。结论是,除了BP外,促炎细胞因子,尤其是TNF-α,似乎与终末期肾病(ESRD)患者的LVH有关。